Okami Medical Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series F
- Latest Deal Amount
-
$43.1M
- Investors
-
6
Okami Medical General Information
Description
Developer of a peripheral embolization device designed to treat cardiovascular disease for the occlusion of peripheral vessels. The company's device is used to obstruct or reduce the rate of blood flow in arteries of the peripheral vasculature and is highly stable after placement, enabling physicians to access and rapidly occlude a wide range of vascular targets.
Contact Information
Website
www.okamimedical.comCorporate Office
- 8 Argonaut
- Suite 100
- Aliso Viejo, CA 92656
- United States
Corporate Office
- 8 Argonaut
- Suite 100
- Aliso Viejo, CA 92656
- United States
Okami Medical Timeline
Okami Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series F) | 19-Nov-2025 | $43.1M | Completed | Generating Revenue | ||
| 8. Mezzanine | 24-Jun-2025 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series F) | 21-Oct-2024 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series E) | 14-Sep-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 10-Jun-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 15-Apr-2019 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 23-Jun-2017 | Completed | Generating Revenue | |||
| 2. Seed Round | 25-May-2016 | $1.65M | $1.65M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Startup |
Okami Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series F-1 | ||||||||
| Series F-2 | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 274,383 | $0.001000 | $16.4 | $16.4 | 1x | $16.4 | 0.79% | |
| Series A | 165,000 | $0.001000 | $10 | $10 | 1x | $10 | 0.47% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Okami Medical Comparisons
Industry
Financing
Details
Okami Medical Competitors (24)
One of Okami Medical’s 24 competitors is Access Vascular, a Venture Capital-Backed company based in Billerica, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Access Vascular | Venture Capital-Backed | Billerica, MA | ||||
| Penumbra | Formerly VC-backed | Alameda, CA | ||||
| Elixir Medical | Venture Capital-Backed | Milpitas, CA | ||||
| Vesper Medical | Formerly VC-backed | Wayne, PA | ||||
| Lemaitre Vascular | Formerly PE-Backed | Burlington, MA |
Okami Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Okami Medical Patents
Okami Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3706644-A1 | Interlocking loop coupling/decoupling system for deploying vascular implant devices | Active | 09-Nov-2017 | ||
| EP-3706644-A4 | Interlocking loop coupling/decoupling system for deploying vascular implant devices | Active | 09-Nov-2017 | ||
| EP-3706644-B1 | Interlocking loop coupling/decoupling system for deploying vascular implant devices | Active | 09-Nov-2017 | ||
| EP-3706644-C0 | Interlocking loop coupling/decoupling system for deploying vascular implant devices | Active | 09-Nov-2017 | ||
| US-10531877-B2 | Interlocking loop coupling/decoupling system for deploying vascular implant devices | Active | 09-Nov-2017 | A61B17/12109 |
Okami Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Okami Medical Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gilde Healthcare | PE/Buyout | Minority | ||
| Eagle Point Trinity Senior Secured Lending Company BDC | Mezzanine | Minority | ||
| Trinity Capital (Phoenix) | Asset Manager | Minority | ||
| Vensana Capital | Venture Capital | Minority | ||
| U.S. Venture Partners | Venture Capital | Minority |
Okami Medical FAQs
-
When was Okami Medical founded?
Okami Medical was founded in 2011.
-
Where is Okami Medical headquartered?
Okami Medical is headquartered in Aliso Viejo, CA.
-
What is the size of Okami Medical?
Okami Medical has 8 total employees.
-
What industry is Okami Medical in?
Okami Medical’s primary industry is Surgical Devices.
-
Is Okami Medical a private or public company?
Okami Medical is a Private company.
-
What is the current valuation of Okami Medical?
The current valuation of Okami Medical is .
-
What is Okami Medical’s current revenue?
The current revenue for Okami Medical is .
-
How much funding has Okami Medical raised over time?
Okami Medical has raised $104M.
-
Who are Okami Medical’s investors?
Gilde Healthcare, Eagle Point Trinity Senior Secured Lending Company BDC, Trinity Capital (Phoenix), Vensana Capital, and U.S. Venture Partners are 5 of 6 investors who have invested in Okami Medical.
-
Who are Okami Medical’s competitors?
Access Vascular, Penumbra, Elixir Medical, Vesper Medical, and Lemaitre Vascular are some of the 24 competitors of Okami Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
